Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials

British Medical Journal

Volumn 324, Issue 7339, 2002, Pages 705-708

  Pickup, John ^a   Mattock, Martin ^b   Kerry, Sally ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST HELIER HOSPITAL   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HUMAN; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; RANDOMIZED CONTROLLED TRIALS;

EID: 0037160919     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Continuous subcutaneous insulin infusion: An approach to achieving normoglycaemia
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
3. Bias in meta-analysis detected by a simple graphical test
4. Intensive conventional and insulin pump therapy in adult type 1 diabetes. A crossover study
5. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: Improved control with CSII
6. Effect of near-normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo study
7. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study
8. Intensified insulin therapy in the type 1 diabetic adolescent: A controlled trial
9. A crossover comparison of continuous insulin infusion and conventional injection treatment of type 1 diabetes
10. Continuous subcutaneous insulin infusion versus injection therapy: A randomized cross-over trial under usual diabetic clinic conditions
11. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients
12. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen
13. Effect of pump versus pen treatment on glycaemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM)
14. Comparison of continuous subcutaneous insulin infusion and intensified conventional therapy in the treatment of type 1 diabetes: A two-year randomised study
15. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: A randomized study
16. Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM
17. Improved insulin sensitivity in patients with type 1 diabetes mellitus after CSII
18. The absence of a glycemic threshold for the development of long-term complications: The perspective of the diabetes control and complications trial
19. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: A comparison of continuous subcutaneous insulin infusion and conventional insulin therapy
20. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion
21. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes
22. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes
23. Pharmacokinetics of continuous subcutaneous insulin infusion
24. Continuous subcutaneous insulin infusion in type 1 diabetes
25. Is insulin pump treatment justifiable